These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31257599

  • 1. Pilot evaluation of Enterococcus faecium SF68 as adjunctive therapy for oclacitinib-responsive adult atopic dermatitis in dogs.
    Yamazaki C, Rosenkrantz W, Griffin C.
    J Small Anim Pract; 2019 Aug; 60(8):499-506. PubMed ID: 31257599
    [Abstract] [Full Text] [Related]

  • 2. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
    Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI, King VI, Tena JK, Stegemann MR.
    Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
    [Abstract] [Full Text] [Related]

  • 3. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR, King VL, Davis KR, Cosgrove SB, Stegemann MR.
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
    Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR.
    Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prolonged twice-daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client-owned atopic dogs.
    Denti D, Caldin M, Ventura L, De Lucia M.
    Vet Dermatol; 2022 Apr; 33(2):149-e42. PubMed ID: 35014745
    [Abstract] [Full Text] [Related]

  • 12. Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
    Marsella R, Ahrens K, Wilkes R, Trujillo A, Dorr M.
    Vet Dermatol; 2020 Aug; 31(4):284-e69. PubMed ID: 32301565
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulatory effect of long-term oclacitinib maleate therapy in dogs with atopic dermatitis.
    De Caro Martins G, da Costa-Val AP, Coura FM, Diamantino GML, Nogueira MM, de Oliveira Melo-Junior OA, Giunchetti RC, da Silveira-Lemos D, Melo MM.
    Vet Dermatol; 2022 Apr; 33(2):142-e40. PubMed ID: 34747068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis.
    Nishiyama T, Kusakabe M, Imanishi I, Hisano T, Fukamachi T, Taguchi N, Iyori K, Hsiao YH.
    Vet Dermatol; 2023 Dec; 34(6):523-531. PubMed ID: 37485602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C, Noli C, Colombo S, Borio S.
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
    Tamamoto-Mochizuki C, Murphy KM, Olivry T.
    Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.